The Anthrax Protective Antigen IgG ELISA Kit detects and quantifies PA83 IgG in human serum or plasma of vaccinated, immunized and/or non-vaccinated individuals. This immunoassay is suitable for:
Determining immune status relative to non-immune controls;
Assessing efficacy of vaccines, including dosage, adjuvantcy, route of immunization and timing;
Qualifying and standardizing vaccine batches & protocols.
The kit contains no anthrax bacteria (live or killed), and is for research use only (RUO), not for diagnosis, cure or prevention of the disease.